Correlation Between Adaptimmune Therapeutics and Alzamend Neuro
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Alzamend Neuro, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Alzamend Neuro.
Diversification Opportunities for Adaptimmune Therapeutics and Alzamend Neuro
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Adaptimmune and Alzamend is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Alzamend Neuro go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Alzamend Neuro
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 1.77 times more return on investment than Alzamend Neuro. However, Adaptimmune Therapeutics is 1.77 times more volatile than Alzamend Neuro. It trades about 0.03 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.21 per unit of risk. If you would invest 73.00 in Adaptimmune Therapeutics Plc on September 1, 2024 and sell it today you would lose (1.00) from holding Adaptimmune Therapeutics Plc or give up 1.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Alzamend Neuro
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Alzamend Neuro |
Adaptimmune Therapeutics and Alzamend Neuro Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Alzamend Neuro
The main advantage of trading using opposite Adaptimmune Therapeutics and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.The idea behind Adaptimmune Therapeutics Plc and Alzamend Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Alzamend Neuro vs. Tff Pharmaceuticals | Alzamend Neuro vs. Eliem Therapeutics | Alzamend Neuro vs. Inhibrx | Alzamend Neuro vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |